Dr. Lal PathLabs Ltd. has shown significant price movement.
Recent Performance: The stock increased by 2.51%.
Support and Resistance Levels:
- Support: ₹2898.10
- Resistance: ₹3217.60
Moving Averages:
- 14 EMA: ₹2972.40
- 7 EMA: ₹2991.96
Key Financial Metrics:
- PE Ratio: 53.20
- EPS: ₹57.67
- Market Cap: ₹25,130 Crores
- Recent Earnings: FY 2023-2024 revenue ₹4,200 Crores, with PAT of ₹520 Crores
Entry, Exit, and Stop Loss:
- Entry Point: Above ₹3100 if signs of recovery are shown
- Exit Point: Near ₹3200 (resistance level)
- Stop Loss: At ₹2950
Disclaimer - Not a Buy/Sell Recommendation.
Recent Performance: The stock increased by 2.51%.
Support and Resistance Levels:
- Support: ₹2898.10
- Resistance: ₹3217.60
Moving Averages:
- 14 EMA: ₹2972.40
- 7 EMA: ₹2991.96
Key Financial Metrics:
- PE Ratio: 53.20
- EPS: ₹57.67
- Market Cap: ₹25,130 Crores
- Recent Earnings: FY 2023-2024 revenue ₹4,200 Crores, with PAT of ₹520 Crores
Entry, Exit, and Stop Loss:
- Entry Point: Above ₹3100 if signs of recovery are shown
- Exit Point: Near ₹3200 (resistance level)
- Stop Loss: At ₹2950
Disclaimer - Not a Buy/Sell Recommendation.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。